NEW YORK, Aug. 18, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
http://www.reportlinker.com/p0591353/Tumor-Marker-Diagnostic-Technologies-Assessment-of-Current-and-Emerging-Technologies-And-Their-Potential-Market-Applications.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic
This 110-page report provides:
- Assessments and potential applications of monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry and biosensors or tumor marker diagnostic testing.
- Review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics spectroscopy.
Contains 110 pages
Table of Contents
Current and Emerging Technologies
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
a. Technological Principle
b. Radioimmunoassay (RIA)
c. Enzyme Immunoassays (EIA)
Overview
ELISA
Immunofiltration
ParticleMembrane Capture Immunoassay
Enzyme Amplification
d. Fluorescent Immunoassays
e. Luminescence
Chemiluminescence
Bioluminescence
3. Molecular Diagnostics
a. Technology Overview
b. Amplification Methods
PCR
DAPPCR
ImmunoPCR
QCPCR
CAR
DNA
HPA
LCR
NASBA
QBR
SDA
3 SR, and others
4. Chromosome Analysis
a. Chronic Myelogenous Leukemia (CML)
b. Acute Myeloid Leukemia (AML)
c. Acute Lymphoblastic Leukemia (ALL)
d. Malignant Lymphomas
Lymphoid Malignancies
e. Chronic Lymphocytic Leukemia (CLL)
f. Solid Cancers
g. Chromosomal Translocation and Oncogenes
5. Artificial Intelligence
6. Flow Cytometry
7. TwoDimensional Gel Eletrophoresis (2DGE)
8. Biosensors
E. Competing/Complementing Technologies
1. CT
2. MRI
3. NMR
4. PET
5.Photonics Spectroscopy
To order this report:
In Vitro Diagnostic Industry: Tumor Marker Diagnostic Technologies: Assessment of Current and Emerging Technologies, And Their Potential Market Applications
In Vitro Diagnostic Business News
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker